Back to Rankings

VRCA

VerricaD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
VRCA vs peer average
42/100
VRCA vs. peer average (D vs. C)
Grade spread
A 1 · B 1 · C 1 · D 3 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

CRDF is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $101.19M

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerCRDFCardiff Oncology
VRCA
Verrica
CRDF
Cardiff Oncology
Grade
D
A
Momentum
46
91
Value
41
41
Sentiment
-
92
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Constructive

Grade position vs CRDF

VRCA / CRDF
Grade Position
Below peers
VRCA vs. peer average (D vs. C)
42/100
Momentum
46
CRDF
Value
41
VRCA
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs VRCA
1
CRDF
Cardiff Oncology Inc Common
A
100/100
-3
2
PEPG
PepGen Inc Common
C
60/100
-1
3
OTLK
Outlook Therapeutics Inc Common
F
20/100
+1
4
BMEA
Biomea Fusion Inc Common
D
40/100
Even
5
ALDX
Aldeyra Therapeutics Inc Common
B
80/100
-2
CRDF is the first peer returned for this comparison set.